← Back
$NAGE All transactions

Niagen Bioscience, Inc.

▲ BUY
6 / 10

Conviction

$ Value

$15K

Shares

2,220

Price

$7

Filed

Nov 17

Why this score? (6/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Pamir Ozan

Title

Chief Financial Officer

CIK

0001834681

Roles

Officer

Transaction Details

Transaction Date

2025-11-14

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

2,220

Footnotes

The weighted average purchase price for the transaction reported was $6.81, and the range of prices were between $6.7975 and $6.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided.

Filing Info

Accession No.

0001834681-25-000005

Form Type

4

Issuer CIK

0001386570

Pamir Ozan's History

Date Ticker Type Value
2026-02-19 NAGE A $0
2025-11-14 NAGE $30K
2025-11-14 NAGE $15K

Other Insiders at NAGE (90d)

Insider Bought Sold Last
Fried Robert N
Chief Executive Officer
2026-02-19
Pamir Ozan
Chief Financial Officer
2026-02-19
Lopez Carlos Luis
SVP, General Counsel
2026-02-19